Cargando…

The association of body mass index with the risk of type 2 diabetes: a case–control study nested in an electronic health records system in the United States

OBJECTIVES: Obesity is a known risk factor for type 2 diabetes (T2D). We conducted a case–control study to assess the association between body mass index (BMI) and the risk of being diagnosed with T2D in the United States. METHODS: We selected adults (≥ 18 years old) who were diagnosed with T2D (def...

Descripción completa

Detalles Bibliográficos
Autores principales: Ganz, Michael L, Wintfeld, Neil, Li, Qian, Alas, Veronica, Langer, Jakob, Hammer, Mette
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3976458/
https://www.ncbi.nlm.nih.gov/pubmed/24694251
http://dx.doi.org/10.1186/1758-5996-6-50
_version_ 1782310298398490624
author Ganz, Michael L
Wintfeld, Neil
Li, Qian
Alas, Veronica
Langer, Jakob
Hammer, Mette
author_facet Ganz, Michael L
Wintfeld, Neil
Li, Qian
Alas, Veronica
Langer, Jakob
Hammer, Mette
author_sort Ganz, Michael L
collection PubMed
description OBJECTIVES: Obesity is a known risk factor for type 2 diabetes (T2D). We conducted a case–control study to assess the association between body mass index (BMI) and the risk of being diagnosed with T2D in the United States. METHODS: We selected adults (≥ 18 years old) who were diagnosed with T2D (defined by ICD-9-CM diagnosis codes or use of anti-diabetic medications) between January 2004 and October 2011 (“cases”) from an electronic health records database provided by an integrated health system in the Middle Atlantic region. Twice as many individuals enrolled in the health system without a T2D diagnosis during the study period (“controls”) were selected based on age, sex, history of cardiac comorbidities or hyperinflammatory state (defined by C-reactive protein and erythrocyte sedimentation rate), and use of psychiatric or beta blocker medications. BMI was measured during one year prior to the first observed T2D diagnosis (for cases) or a randomly assigned date (for controls); individuals with no BMI measure or BMI < 18.5 kg/m(2) were excluded. We assessed the impact of increased BMI (overweight: 25–29.9 kg/m(2); Obesity Class I: 30–34.9 kg/m(2); Obesity Class II: 35–39.9 kg/m(2); Obesity Class III: ≥40 kg/m(2)), relative to normal BMI (18.5–24.9 kg/m(2)), on a T2D diagnosis using odds ratios (OR) and relative risks (RR) estimated from multiple logistic regression results. RESULTS: We included 12,179 cases (mean age: 55, 43% male) and 25,177 controls (mean age: 56, 45% male). We found a positive association between BMI and the risk of a T2D diagnosis. The strength of this association increased with BMI category (RR [95% confidence interval]: overweight, 1.5 [1.4–1.6]; Obesity Class I, 2.5 [2.3–2.6]; Obesity Class II, 3.6 [3.4–3.8]; Obesity Class III, 5.1 [4.7–5.5]). CONCLUSIONS: BMI is strongly and independently associated with the risk of being diagnosed with T2D. The incremental association of BMI category on the risk of T2D is stronger for people with a higher BMI relative to people with a lower BMI.
format Online
Article
Text
id pubmed-3976458
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-39764582014-04-06 The association of body mass index with the risk of type 2 diabetes: a case–control study nested in an electronic health records system in the United States Ganz, Michael L Wintfeld, Neil Li, Qian Alas, Veronica Langer, Jakob Hammer, Mette Diabetol Metab Syndr Research OBJECTIVES: Obesity is a known risk factor for type 2 diabetes (T2D). We conducted a case–control study to assess the association between body mass index (BMI) and the risk of being diagnosed with T2D in the United States. METHODS: We selected adults (≥ 18 years old) who were diagnosed with T2D (defined by ICD-9-CM diagnosis codes or use of anti-diabetic medications) between January 2004 and October 2011 (“cases”) from an electronic health records database provided by an integrated health system in the Middle Atlantic region. Twice as many individuals enrolled in the health system without a T2D diagnosis during the study period (“controls”) were selected based on age, sex, history of cardiac comorbidities or hyperinflammatory state (defined by C-reactive protein and erythrocyte sedimentation rate), and use of psychiatric or beta blocker medications. BMI was measured during one year prior to the first observed T2D diagnosis (for cases) or a randomly assigned date (for controls); individuals with no BMI measure or BMI < 18.5 kg/m(2) were excluded. We assessed the impact of increased BMI (overweight: 25–29.9 kg/m(2); Obesity Class I: 30–34.9 kg/m(2); Obesity Class II: 35–39.9 kg/m(2); Obesity Class III: ≥40 kg/m(2)), relative to normal BMI (18.5–24.9 kg/m(2)), on a T2D diagnosis using odds ratios (OR) and relative risks (RR) estimated from multiple logistic regression results. RESULTS: We included 12,179 cases (mean age: 55, 43% male) and 25,177 controls (mean age: 56, 45% male). We found a positive association between BMI and the risk of a T2D diagnosis. The strength of this association increased with BMI category (RR [95% confidence interval]: overweight, 1.5 [1.4–1.6]; Obesity Class I, 2.5 [2.3–2.6]; Obesity Class II, 3.6 [3.4–3.8]; Obesity Class III, 5.1 [4.7–5.5]). CONCLUSIONS: BMI is strongly and independently associated with the risk of being diagnosed with T2D. The incremental association of BMI category on the risk of T2D is stronger for people with a higher BMI relative to people with a lower BMI. BioMed Central 2014-04-03 /pmc/articles/PMC3976458/ /pubmed/24694251 http://dx.doi.org/10.1186/1758-5996-6-50 Text en Copyright © 2014 Ganz et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Ganz, Michael L
Wintfeld, Neil
Li, Qian
Alas, Veronica
Langer, Jakob
Hammer, Mette
The association of body mass index with the risk of type 2 diabetes: a case–control study nested in an electronic health records system in the United States
title The association of body mass index with the risk of type 2 diabetes: a case–control study nested in an electronic health records system in the United States
title_full The association of body mass index with the risk of type 2 diabetes: a case–control study nested in an electronic health records system in the United States
title_fullStr The association of body mass index with the risk of type 2 diabetes: a case–control study nested in an electronic health records system in the United States
title_full_unstemmed The association of body mass index with the risk of type 2 diabetes: a case–control study nested in an electronic health records system in the United States
title_short The association of body mass index with the risk of type 2 diabetes: a case–control study nested in an electronic health records system in the United States
title_sort association of body mass index with the risk of type 2 diabetes: a case–control study nested in an electronic health records system in the united states
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3976458/
https://www.ncbi.nlm.nih.gov/pubmed/24694251
http://dx.doi.org/10.1186/1758-5996-6-50
work_keys_str_mv AT ganzmichaell theassociationofbodymassindexwiththeriskoftype2diabetesacasecontrolstudynestedinanelectronichealthrecordssystemintheunitedstates
AT wintfeldneil theassociationofbodymassindexwiththeriskoftype2diabetesacasecontrolstudynestedinanelectronichealthrecordssystemintheunitedstates
AT liqian theassociationofbodymassindexwiththeriskoftype2diabetesacasecontrolstudynestedinanelectronichealthrecordssystemintheunitedstates
AT alasveronica theassociationofbodymassindexwiththeriskoftype2diabetesacasecontrolstudynestedinanelectronichealthrecordssystemintheunitedstates
AT langerjakob theassociationofbodymassindexwiththeriskoftype2diabetesacasecontrolstudynestedinanelectronichealthrecordssystemintheunitedstates
AT hammermette theassociationofbodymassindexwiththeriskoftype2diabetesacasecontrolstudynestedinanelectronichealthrecordssystemintheunitedstates
AT ganzmichaell associationofbodymassindexwiththeriskoftype2diabetesacasecontrolstudynestedinanelectronichealthrecordssystemintheunitedstates
AT wintfeldneil associationofbodymassindexwiththeriskoftype2diabetesacasecontrolstudynestedinanelectronichealthrecordssystemintheunitedstates
AT liqian associationofbodymassindexwiththeriskoftype2diabetesacasecontrolstudynestedinanelectronichealthrecordssystemintheunitedstates
AT alasveronica associationofbodymassindexwiththeriskoftype2diabetesacasecontrolstudynestedinanelectronichealthrecordssystemintheunitedstates
AT langerjakob associationofbodymassindexwiththeriskoftype2diabetesacasecontrolstudynestedinanelectronichealthrecordssystemintheunitedstates
AT hammermette associationofbodymassindexwiththeriskoftype2diabetesacasecontrolstudynestedinanelectronichealthrecordssystemintheunitedstates